Results of a retrospective study of a racially diverse population demonstrated positive outcomes for patients with NSCLC who experience irAEs when treated with immune checkpoint inhibitors.

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.

The predictive model demonstrated an 8-year cumulative incidence of TKI failure in the training set of 10% in the low-risk group, 34% in the intermediate risk, and 69% in the high-risk. In the ...

The median progression-free survival was 6.8 months, and the median overall survival was 19.1 months. Pegylated liposomal doxorubicin (PLD) has demonstrated safety and efficacy in patients with ...

All patients receiving surgery/radiotherapy alone or with chemotherapy had improvement or stability of alopecia with LDOM.

Among patients with early-stage malignant melanoma who underwent standard excision, the incidence of residual melanoma tumor cells in tissue from a wide local excision was low, at less than 5% of ...

Recent research bolsters the case that radiotherapy to treat primary endometrial cancer is associated with an increased risk ...

The cancer-specific mortality rate decreased by 1.5% annually from 1999 through 2020. Asian American and Pacific Islander (AAPI) patients in the US experienced an overall decline in cancer ...

Overall remission occurred in 77 percent of patients in a cohort with morphologic disease. HealthDay News — For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL ...

While Hematotox-Score is valuable for predicting early hematologic toxicity, its inability to predict survival outcomes underscores its limitations. The Hematotox-Score demonstrated predictive ...

Researchers sought to determine whether chemotherapy consolidated by autoSCT would yield the same survival results as alloSCT in patients with PTCL.